Reference
- Befeler B., Castellanos A., Jr, Wells D. E., Vagueiro M. C., Yeh B. K. Electrophysiologic effects of the anti-arrhythmic agent disopyramide phosphate. Am. J. Cardiol. 1975; 35: 2821. Befeler B., Castellanos A., Jr, Wells D. E., Vagueiro M. C., Yeh B. K. Electrophysiologic effects of the anti-arrhythmic agent disopyramide phosphate. Am. J. Cardiol. 1975; 35: 282
- Besterman E. M. M. A double-blind study on the effect of oral disopyramide in the prophylaxis of arrhythmias following acute myocardial infarction. Br. J. Clin. Pharmacol. 1975; 2: 1862. Besterman E. M. M. A double-blind study on the effect of oral disopyramide in the prophylaxis of arrhythmias following acute myocardial infarction. Br. J. Clin. Pharmacol. 1975; 2: 186
- Danilo P., Jr, Rosen M. R. Cardiac effects of disopyramide. Am. Heart J. 1976; 92: 5323. Danilo P., Jr, Rosen M. R. Cardiac effects of disopyramide. Am. Heart J. 1976; 92: 532
- Desai J. M., Scheinman M., Peters R. W., O'Young J. D. Electrophysiological effects of disopyramide in patients with bundle branch block. Circulation 1979; 59: 2154. Desai J. M., Scheinman M., Peters R. W., O'Young J. D. Electrophysiological effects of disopyramide in patients with bundle branch block. Circulation 1979; 59: 215
- Duchateau A. M. J. A., Merkus F. W. H. M., Schobben F. Rapid gas chromatographic determination of disopyramide in serum using a nitrogen detector. J. Chromatogr. 1975; 109: 4325. Duchateau A. M. J. A., Merkus F. W. H. M., Schobben F. Rapid gas chromatographic determination of disopyramide in serum using a nitrogen detector. J. Chromatogr. 1975; 109: 432
- Hutling J., Rosenhamer G. Disopyramide in ventricular tachycardia. Acta Med. Scand. 1976; 200: 2096. Hutling J., Rosenhamer G. Disopyramide in ventricular tachycardia. Acta Med. Scand. 1976; 200: 209
- Jennings G., Model D. G., Jones M. B. S., Turner P. P., Besterman E. M. M., Kidner P. H. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction. Lancet 1976; 1: 517. Jennings G., Model D. G., Jones M. B. S., Turner P. P., Besterman E. M. M., Kidner P. H. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction. Lancet 1976; 1: 51
- Johnston A., Mchaffie D. Gas-liquid chromatographic method for the routine estimation of disopyramide in plasma or serum. J. Chromatogr. 1978; 152: 5018. Johnston A., Mchaffie D. Gas-liquid chromatographic method for the routine estimation of disopyramide in plasma or serum. J. Chromatogr. 1978; 152: 501
- Katz M. J., Meyer C. E., El-Etr A., Slodki S. J. Clinical evaluation of a new anti-arrhythmic agent, SC-7031. Curr. Ther. Res. 1963; 5: 3439. Katz M. J., Meyer C. E., El-Etr A., Slodki S. J. Clinical evaluation of a new anti-arrhythmic agent, SC-7031. Curr. Ther. Res. 1963; 5: 343
- Labarre A., Strauss H. C., Scheinman M. M., Th Evans G., Bashore Th., Tiedeman J. S., Wallace A. G. Electrophysiologic effects of disopyramide phosphate on sinus node function in patients with sinus node dysfunction. Circulation 1979; 59: 22610. Labarre A., Strauss H. C., Scheinman M. M., Th Evans G., Bashore Th., Tiedeman J. S., Wallace A. G. Electrophysiologic effects of disopyramide phosphate on sinus node function in patients with sinus node dysfunction. Circulation 1979; 59: 226
- Mathur P. P. Cardiovascular effects of newer anti-arrhythmic agent, disopyramide phosphate. Am. Heart J. 1972; 84: 76411. Mathur P. P. Cardiovascular effects of newer anti-arrhythmic agent, disopyramide phosphate. Am. Heart J. 1972; 84: 764
- Mizgala H. F., Huvelle P. R. Acute termination of cardiac arrhythmias with intravenous disopyramide. J. Int. Med. Res. 1976; 4: 82, Suppl. 112. Mizgala H. F., Huvelle P. R. Acute termination of cardiac arrhythmias with intravenous disopyramide. J. Int. Med. Res. 1976; 4: 82, Suppl. 1
- Mokler C. M., Van Arman C. G. Pharmacology of a new anti-arrhythmic agent, y-diisopropylanuno-x-phenyl-x-(2-pyridyl)-butyramide (SC-7031). J. Pharm. Exp. Ther. 1962; 136: 11413. Mokler C. M., Van Arman C. G. Pharmacology of a new anti-arrhythmic agent, y-diisopropylanuno-x-phenyl-x-(2-pyridyl)-butyramide (SC-7031). J. Pharm. Exp. Ther. 1962; 136: 114
- Niarchos A. D. Disopyramide-serum level and arrhythmia conversion. Am. Heart J. 1976; 92: 5714. Niarchos A. D. Disopyramide-serum level and arrhythmia conversion. Am. Heart J. 1976; 92: 57
- Vismara L. A., Mason D. T., Amsterdam E. A. Disopyramide phosphate: clinical efficacy of a new oral anti-arrhythmic drug. Clin. Pharmacol. Ther. 1974; 16: 33015. Vismara L. A., Mason D. T., Amsterdam E. A. Disopyramide phosphate: clinical efficacy of a new oral anti-arrhythmic drug. Clin. Pharmacol. Ther. 1974; 16: 330
- Vismara L. A., Vera Z., Miller R. R., Mason D. T. Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia. Am. J. Cardiol. 1977; 39: 102716. Vismara L. A., Vera Z., Miller R. R., Mason D. T. Efficacy of disopyramide phosphate in the treatment of refractory ventricular tachycardia. Am. J. Cardiol. 1977; 39: 1027
- Zainal N., Carmicheal D. J. S., Griffiths J. W., Besterman E. M. M., Kidner P. H., Gillham A. D., Summers G. D. Oral disopyramide for the prevention of arrhythmias in patients with myocardial infarction admitted to open wards. Lancet 1977; 2: 88717. Zainal N., Carmicheal D. J. S., Griffiths J. W., Besterman E. M. M., Kidner P. H., Gillham A. D., Summers G. D. Oral disopyramide for the prevention of arrhythmias in patients with myocardial infarction admitted to open wards. Lancet 1977; 2: 887